ライフサイエンスコーパス: keratoconjunctivitis

1 stically significant risk factors for vernal keratoconjunctivitis.

2 year after surgery to monitor the status of keratoconjunctivitis.

3 al visual outcome in cases of microsporidial keratoconjunctivitis.

4 , gastroenteritis, hemorrhagic cystitis, and keratoconjunctivitis.

5 addition to treatment of epidemic adenoviral keratoconjunctivitis.

6 V-37) is a major etiologic agent of epidemic keratoconjunctivitis, a common and severe eye infection

7 Similar to other forms of toxic keratoconjunctivitis, a detailed history and careful cli

8 genotypes within HAdV species D and epidemic keratoconjunctivitis, a severe ocular surface infection.

9 prevalence and associated factors of vernal keratoconjunctivitis among children living in Gondar Cit

10 The association between vernal keratoconjunctivitis and factors such as socio-economic,

11 spectively) are causative agents of epidemic keratoconjunctivitis and genital tract infections.

12 Superior limbic keratoconjunctivitis and lagophthalmos are prognostic ma

13 63 patients clinically diagnosed with vernal keratoconjunctivitis and shield ulcers.

14 63 patients clinically diagnosed with vernal keratoconjunctivitis and shield ulcers.

15 such as keratoconjunctivitis sicca, allergic keratoconjunctivitis, and corneal allograft rejection.

16 ncluding ocular cicatrial pemphigoid, vernal keratoconjunctivitis, and pterygium.

17 37 (Ad37), a virus associated with epidemic keratoconjunctivitis, but not a closely related virus se

18 ance system revealed an increase of epidemic keratoconjunctivitis (EKC) from an average of 320 cases/

19 (HAdV-D19) has been associated with epidemic keratoconjunctivitis (EKC), a highly inflammatory infect

20 ludes those viruses associated with epidemic keratoconjunctivitis (EKC), a severe ocular surface infe

21 Moreover, the animals were protected against keratoconjunctivitis following conjunctival challenge wi

22 date for a vaccine against infectious bovine keratoconjunctivitis (IBK) has been cloned and character

23 Infectious Bovine Keratoconjunctivitis (IBK) in beef cattle, commonly know

24 Infectious bovine keratoconjunctivitis (IBK) is a highly contagious ocular

25 pe 37 (Ad37), a subgroup D virus that causes keratoconjunctivitis in humans, does not infect cells vi

26 There is a high prevalence of vernal keratoconjunctivitis in this region.

27 of an inflammatory cytokine associated with keratoconjunctivitis, interleukin-1beta (P = 0.025), in

28 The lacrimal keratoconjunctivitis (LKC) was mediated by CD4(+) T cell

29 directed against shigellosis, the guinea pig keratoconjunctivitis model was used to evaluate the adju

30 Guinea pigs (keratoconjunctivitis model) or mice (lethal lung model)

31 In the guinea pig keratoconjunctivitis model, a Shigella pic mutant induce

32 and protective efficacy using the guinea pig keratoconjunctivitis model.

33 immunogenic and protective in the guinea pig keratoconjunctivitis model.

34 to be more susceptible to developing chronic keratoconjunctivitis (rs1478604: odds ratio [OR], 2.5; 9

35 challenge with wild-type S. flexneri 2a in a keratoconjunctivitis Sereny test.

36 The commonest ocular manifestation was keratoconjunctivitis sicca (11.3%) followed by blepharit

37 ues, resulting in xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes).

38 to generate an inducible autoimmune model of keratoconjunctivitis sicca (KCS) for study of pathogenes

39 une; Sandoz, Basel, Switzerland) in treating keratoconjunctivitis sicca (KCS) include an effect on th

40 Keratoconjunctivitis sicca (KCS) is characterized by inf

41 ta, and MMP-9, similar to that seen in human keratoconjunctivitis sicca (KCS) or "dry eyes." Therefor

42 surface epithelial changes resembling human keratoconjunctivitis sicca (KCS) that are exacerbated by

43 initiating inflammatory responses leading to keratoconjunctivitis sicca (KCS), autoimmunity, and Sjog

44 genesis of goblet cell deficiency-associated keratoconjunctivitis sicca (KCS, or dry eye).

45 control subjects (C), 73 with non-Sjogren's keratoconjunctivitis sicca (non-SS KCS) and 21 with Sjog

46 ssment of 210 people, 130 with non-Sjogren's keratoconjunctivitis sicca (non-SS KCS), 32 with Sjogren

47 s may play a key role in the pathogenesis of keratoconjunctivitis sicca and may be a therapeutic targ

48 mmon autoimmune rheumatic disease, refers to keratoconjunctivitis sicca and xerostomia resulting from

49 autoimmune disease that is characterized by keratoconjunctivitis sicca and xerostomia resulting from

50 ropean Americans) that typically presents as keratoconjunctivitis sicca and xerostomia.

51 xperimental dry eye models and patients with keratoconjunctivitis sicca due to the induction of inter

52 degeneration, neuroophthalmic disorders, and keratoconjunctivitis sicca in patients with HTLV-1-assoc

53 p in our understanding of the dacryoadenitis/keratoconjunctivitis sicca in this model.

54 Keratoconjunctivitis sicca is a common ocular surface di

55 ces in pathogenesis include the concept that keratoconjunctivitis sicca is a condition of abnormal gr

56 These findings indicate that keratoconjunctivitis sicca may represent a chronic wound

57 Keratoconjunctivitis sicca was induced bilaterally in si

58 are extreme tiredness, along with dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia).

59 the immunopathogeneses of conditions such as keratoconjunctivitis sicca, allergic keratoconjunctiviti

60 IgG, IgA, keratoconjunctivitis sicca, and sex, identified as the b

61 eatures of ocular graft versus host disease (keratoconjunctivitis sicca, cicatricial conjunctivitis,

62 to investigate autoimmune dacryoadenitis and keratoconjunctivitis sicca, features of SS.

63 Ocular findings include keratoconjunctivitis sicca, pseudomembranous conjunctivi

64 e implant was effective in a canine model of keratoconjunctivitis sicca, with all animals able to dis

65 vide insight into the immune pathogenesis of keratoconjunctivitis sicca.

66 d efficacy in a clinically relevant model of keratoconjunctivitis sicca.

67 canine model of aqueous tear deficiency and keratoconjunctivitis sicca.

68 enatal death, vulva and clitoral defects and keratoconjunctivitis sicca.

69 moderate to severe dry eye disease caused by keratoconjunctivitis sicca.

70 ocular surface inflammation that mimic human keratoconjunctivitis sicca.

71 1 may play a key role in the pathogenesis of keratoconjunctivitis sicca.

72 novirus type 19 is a major cause of epidemic keratoconjunctivitis, the only ocular adenoviral infecti

73 inical presentation consistent with epidemic keratoconjunctivitis (type 37 [n = 6], 8 [n = 4], 4 [n =

74 owing were positively associated with vernal keratoconjunctivitis: use of kerosene/firewood for cooki

75 Understanding and treating vernal keratoconjunctivitis (VKC) has been a challenge because

76 appropriate eye care in children with vernal keratoconjunctivitis (VKC) in Rwanda (Central Africa).

77 Vernal keratoconjunctivitis (VKC) is a common cause of ocular m

78 Vernal keratoconjunctivitis (VKC) is a severe ocular allergy wi

79 The prevalence of vernal keratoconjunctivitis was 5.8 % (95 % CI: 4.14, 7.53) (43

80 s of 14 healthy patients with microsporidial keratoconjunctivitis were diagnosed based on the detecti

81 res suggestive of microsporidial superficial keratoconjunctivitis were included in the study.

82 on, suggestive of microsporidial superficial keratoconjunctivitis, were included in the prospective s

83 animals were significantly protected against keratoconjunctivitis (zero of eight vaccinees versus fiv